Regulatory PathRegulatory requirements compared

Active substance

Sunitinib malate

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
SUTENTEQ 12.5MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 37.5MG BASEcapsule · oralCPPI CVPrescription26 Jan 2006
SUTENTEQ 12.5MG BASE; EQ 25MG BASE; EQ 50MG BASEcapsule · oralCPPI CVPrescription26 Jan 2006
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralSUN PHARMPrescription16 Aug 2021
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralTEVA PHARMS USAPrescription30 Nov 2021
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralMYLANPrescription6 Dec 2021
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralDR REDDYSPrescription11 Apr 2022
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralFOSUN WANBANGPrescription21 Aug 2023
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralNATCO PHARMAPrescription24 Oct 2023
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralEUGIA PHARMAPrescription14 Mar 2024
SUNITINIB MALATEEQ 12.5MG BASE; EQ 25MG BASE; EQ 37.5MG BASE; EQ 50MG BASEcapsule · oralMSNPrescription14 Feb 2025

Safety signals and safety-related labeling changes

  • US FDA 30 Aug 2021 SUTENT — safety-related labeling change
    Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide

All safety entries for sunitinib malate →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.